StockGlow

Royalty Pharma plc (RPD.F)

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

50.99+0.02%Healthcare
Compare RPD.F with
StockGlow Score
94
Bullish
BearishBullish
1 year ago+62.2%

The outlook

Royalty Pharma plc currently reads as bullish based on above its 50- & 200-day averages, 92% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range92% of the way from its 52-week low to high
Market cap
$29.36B
52-wk high
52.93
52-wk low
28.87
50-day avg
47.84
200-day avg
39.35
Trailing P/E
30.5

Similar stocks

TE1.FBio-Techne Corporation$62.90+0.61%RPD.MURoyalty Pharma plc$51.83+0.00%DUL.FAlnylam Pharmaceuticals, Inc.$180.00+1.01%RV7.FHalozyme Therapeutics, Inc.$72.16-0.39%BM8.FBioMarin Pharmaceutical Inc.$53.20-0.93%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy